[144] Kura Oncology, Inc. SEC Filing

Rhea-AI Filing Summary

Kura Oncology Form 144 notice reporting a proposed sale of 12,314 shares of common stock. The filer intends to sell the shares through Morgan Stanley Smith Barney LLC on NASDAQ around 09/29/2025, with an aggregate market value listed at $111,441.70. The shares were acquired two days earlier on 09/27/2025 as performance stock units (PSUs) issued by the company and are to be paid/settled on 09/29/2025. The filing states there were no other securities sold by the same person in the past three months and includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Insider sale of recently issued PSUs, small relative to outstanding shares; appears procedural rather than market-moving.

The notice documents a proposed sale of 12,314 common shares acquired as performance stock units two days prior to the intended sale. At an aggregate value of $111,441.70 against 87,015,518 shares outstanding, the transaction represents a de minimis portion of the capital base. The timing—immediate post-issuance settlement—and the seller's attestation of no undisclosed material information suggest a routine disposition of vested compensation rather than a sale prompted by company-specific adverse developments. No other recent sales by the same person are reported.

Corporate Governance Specialist

TL;DR: Filing documents compliant Rule 144 sale of PSUs; disclosure is standard and contains required attestations.

The Form 144 provides required broker, share count, acquisition method (PSU), and settlement timing. The broker identified is Morgan Stanley Smith Barney LLC and the planned execution venue is NASDAQ. The signer makes the statutory representation about lack of undisclosed material information and the form indicates no aggregated prior sales. From a governance and compliance perspective, the filing meets procedural requirements for public disclosure of an insider sale tied to compensation vesting.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12314	111441.7	87015518	09/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/27/2025	PSU	Issuer			12314	09/29/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did KURA's Form 144 report on proposed sales?

The filing reports a proposed sale of 12,314 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, planned for 09/29/2025, with aggregate market value $111,441.70.

What was the acquisition type and date for the shares in the KURA filing?

The shares were acquired as performance stock units (PSUs) on 09/27/2025 from the issuer.

Does the KURA Form 144 show other recent sales by the same person?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are listed in the KURA Form 144?

The broker is Morgan Stanley Smith Barney LLC and the exchange named is NASDAQ.

Is there any assertion about undisclosed material information in the filing?

Yes. The filer represents by signature that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.